The Fundación Noelia has funded an innovative study led by researcher Virginia Arechavala-Gomeza, which takes a step forward in the diagnosis and development of treatments for Congenital Muscular Dystrophy due to Collagen Deficiency VI (CMD COL6). Researchers have created a…
Below we leave you the article published by Dr. Astrid Brull, Member of the NINDS-NIH (USA) Research team, in the American Society of Gene & Cell Therapy with the title "Optimized allele-specific silencing of the dominant-negative COL6A1 G293R substitution causing…
In a recent article, Biopharma Reporter magazine highlights the significant advances that have occurred in recent years in the field of gene therapy, transforming it from a futuristic promise to a concrete reality with treatments already available. These represent a…
On February 23rd, 2021, we participated in one of the seminars organized by ASEM Catalonia: COVID-19 vaccine and neuromuscular diseases, a virtual lecture given by Dr. Olivé, neurologist at Sant Pau University Hospital and Dr. Natera, neuropediatrician at the Sant…
In recent years, news have emerged from time to time that point to the potential benefit of some drugs for congenital muscular dystrophy patients. Although they do not hope to cure the disease, these drugs do seek to alleviate the…
